alpha-hydroxymetoprolol has been researched along with sarpogrelate in 1 studies
Studies (alpha-hydroxymetoprolol) | Trials (alpha-hydroxymetoprolol) | Recent Studies (post-2010) (alpha-hydroxymetoprolol) | Studies (sarpogrelate) | Trials (sarpogrelate) | Recent Studies (post-2010) (sarpogrelate) |
---|---|---|---|---|---|
59 | 6 | 12 | 229 | 45 | 90 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, SH; Bae, SK; Cho, DY; Kim, BT; Kim, YW; Lee, JK; Lee, S; Oh, E; Park, JB | 1 |
1 trial(s) available for alpha-hydroxymetoprolol and sarpogrelate
Article | Year |
---|---|
Effect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers.
Topics: Administration, Oral; Adult; Area Under Curve; Asian People; Cytochrome P-450 CYP2D6 Inhibitors; Healthy Volunteers; Humans; Male; Metoprolol; Middle Aged; Republic of Korea; Succinates; Young Adult | 2015 |